Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

Abstract

BACKGROUND Excess cardiovascular mortality has been documented in chronic haemodialysis patients. Oxidative stress is greater in haemodialysis patients with prevalent cardiovascular disease than in those without, suggesting a role for oxidative stress in excess cardiovascular disease in haemodialysis. We investigated the effect of high-dose vitamin E… (More)

Topics

Cite this paper

@article{Boaz2000SecondaryPW, title={Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.}, author={Mona Boaz and Shmuel Smetana and Tomer Weinstein and Zippora Matas and Uzi Gafter and Adrian Iaina and Anne K. Knecht and Yehoshua Weissgarten and D. Brunner and Menahem Fainaru and M. S. Green}, journal={Lancet}, year={2000}, volume={356 9237}, pages={1213-8} }